Daniel Arias
Stock Analyst at Stifel
(5.00)
# 8
Out of 4,918 analysts
155
Total ratings
53.93%
Success rate
148.59%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Hold | $120 → $110 | $88.23 | +24.67% | 2 | Jul 29, 2025 | |
| BRKR Bruker | Maintains: Hold | $57 → $48 | $37.99 | +26.35% | 8 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $54.89 | +9.31% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $41.42 | +44.86% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $11.36 | +23.24% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $463.04 | +33.90% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $197.09 | +31.92% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.05 | +339.02% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $13.08 | +37.61% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $6.42 | -6.54% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,550 → $1,450 | $1,197.23 | +21.11% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $54.89 | +18.42% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $47.76 | +40.28% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $290.31 | +24.01% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $113.50 | +33.04% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $49.94 | -7.19% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.22 | +350.45% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $118.91 | +74.08% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $94.66 | +111.28% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.69 | +85.87% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.90 | +244.83% | 2 | May 31, 2022 |
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $88.23
Upside: +24.67%
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $37.99
Upside: +26.35%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $54.89
Upside: +9.31%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $41.42
Upside: +44.86%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $11.36
Upside: +23.24%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $463.04
Upside: +33.90%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $197.09
Upside: +31.92%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.05
Upside: +339.02%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $13.08
Upside: +37.61%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.42
Upside: -6.54%
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,197.23
Upside: +21.11%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $54.89
Upside: +18.42%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $47.76
Upside: +40.28%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $290.31
Upside: +24.01%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $113.50
Upside: +33.04%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $49.94
Upside: -7.19%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.22
Upside: +350.45%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $118.91
Upside: +74.08%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $94.66
Upside: +111.28%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.69
Upside: +85.87%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.90
Upside: +244.83%